title: Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies.
abstract: New insights into the pathophysiological mechanisms behind late-onset neurodegenerative diseases have come from unexpected sources in recent years. Specifically, the group of inherited metabolic disorders known as lysosomal storage diseases that most commonly affect infants has been found to have surprising similarities with adult neurodegenerative disorders. Most notable has been the identification of Gaucher's disease as a comorbidity for Parkinson's disease. Prompted by the recent identification of neuronal aggregates of α-synuclein in another lysosomal storage disease, Krabbe's disease, we propose the idea that a similar connection exists between adult synucleinopathies and Krabbe's. Similarities between the two diseases, including the pattern of α-synuclein aggregation in the brain of the twitcher mouse (the authentic murine model of Krabbe's disease), changes to lipid membrane dynamics, and possible dysfunction in synaptic function and macroautophagy, underscore a link between Krabbe's disease and late-onset synucleinopathies. Silent GALC mutations may even constitute a risk factor for the development of Parkinson's in certain patients. More research is required to identify definitively any link and the validity of this hypothesis, but such a connection would prove invaluable for developing novel therapeutic targets for Parkinson's based on our current understanding of Krabbe's disease and for establishing new biomarkers for the identification of at-risk patients. © 2016 Wiley Periodicals, Inc.
authors.affiliation: Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois. mmarsh22@uic.edu.|Graduate Program in Neuroscience, University of Illinois at Chicago, Chicago, Illinois. mmarsh22@uic.edu.|Medical Scientist Training Program, University of Illinois at Chicago, Chicago, Illinois. mmarsh22@uic.edu.
authors.forename: Michael S
authors.identifier: 0000-0002-5742-2031
authors.initials: MS
authors.lastname: Marshall
authors.affiliation: Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois. ebongarz@uic.edu.
authors.forename: Ernesto R
authors.initials: ER
authors.lastname: Bongarzone
mesh_terms: D000818:Animals; D001921:Brain / Q000473:pathology*; D021961:Cell Membrane Structures / Q000473:pathology; D005698:Galactosylceramidase / Q000235:genetics / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D006801:Humans; D007965:Leukodystrophy, Globoid Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008055:Lipids / Q000502:physiology; D009154:Mutation / Q000235:genetics; D009474:Neurons / Q000378:metabolism / Q000473:pathology*; D066329:Protein Aggregates / Q000235:genetics; D051844:alpha-Synuclein / Q000378:metabolism*
chemical_list: D008055:Lipids; D066329:Protein Aggregates; D051844:alpha-Synuclein; D005698:Galactosylceramidase
keywords: Alzheimer's disease; Krabbe's disease; Parkinson's disease; dementia; lysosomal deficiency; neuronal degeneration; psychosine; synaptic failure; α-synuclein